Is Next Chems Still Operating? Domain Status and Exit Rumours

 

The question of whether Next Chems is still operating has become increasingly confused in recent months due to the existence of several distinct entities sharing similar names. To provide a clear answer, it is necessary to separate the legitimate industrial technology provider from the consumer-facing research chemical vendors that have adopted confusingly similar branding.

The Legitimate Nextchem: A Thriving Industrial Giant

If the question refers to Nextchem S.p.A., the subsidiary of the Italian engineering group MAIRE, the answer is an unequivocal yes. Not only is this entity operating, but it is in a phase of aggressive expansion and portfolio diversification. Throughout 2026, Nextchem has announced a series of major contract awards and strategic acquisitions.

In April 2026, Nextchem was awarded licensing and process design packages for a new plant in China based on its proprietary NX CONSER™ C5+ technologies for producing trimellitic anhydride. This was followed in May 2026 by a contract with the U.S. chemical company AdvanSix for a urea-to-diesel exhaust fluid plant in Virginia, leveraging its NX STAMI™ Urea technology. The company has also been active in the sustainable aviation fuel sector, securing projects in Australia and Indonesia.

Most significantly, in June 2026, Nextchem completed the acquisition of the Ballestra Group for a purchase price of €148.2 million. This acquisition added approximately 460 professionals to its workforce and expanded its technology portfolio into the full nitrogen-phosphorus-potassium spectrum for fertilisers, as well as bio-based detergents. Furthermore, in June 2026, Nextchem acquired a 70% stake in ETEK and SISEMTEK, Italian companies specialising in the recovery of critical and precious metals.

The financial outlook for this Nextchem is robust. In March 2026, MAIRE’s CEO Alessandro Bernini stated that Nextchem is “not a startup, but a company that already generates value” and that the group was evaluating options, including a potential IPO or discussions with investors, with valuations potentially reaching €4 billion. For the full year 2026, the group expected revenues of €670–700 million for the Nextchem division, with an EBITDA margin of 22–24%.

The Consumer-Facing “NextChems” Vendors

A separate and entirely unrelated set of entities operates under names like NextChems or Next Chems Peptides, selling research chemicals, peptides, and SARMs directly to consumers. These vendors present a different picture.

According to a vendor review profile on Peptide Protocol Wiki, NextChems is described as a US-based supplier of SARMs, peptides, research chemicals, and nootropics. The profile notes that the company allows customers to request independent HPLC reports and offers a full refund guarantee if products do not match advertised specifications, with free domestic shipping on orders over $100. The vendor received a moderate trust score of 6.9 out of 10.

However, a separate domain has been flagged with a low trust score of 40 by ScamAdviser. The analysis identified several concerning factors: the website owner is using a service to hide their identity on WHOIS, the site has a low traffic rank, and it is hosted on a server with a high number of suspicious websites. The domain was registered in May 2026, making it very young at the time of analysis. ScamAdviser explicitly warned that “the website may be a scam.”

Similarly, received a low trust score from ScamAdviser, with concerns including a hidden owner identity, a young domain age, and a registrar with a high percentage of spammers and fraud sites.

The Pakistan-Based Pharmaceutical Sourcing Entity

A third distinct entity, NextChem, based in Karachi, Pakistan, operates as a “Reliable Pharmaceutical Indenting House", providing raw materials including APIs, excipients, and natural extracts. According to Crustdata, this company was founded in 2020 and had grown to 17 employees by June 2026, representing 21.4% year-over-year headcount growth. However, the same data source noted a concerning signal: web traffic had fallen by 100% quarter-over-quarter, and the company’s overall Growth Score was only 26 out of 100, indicating “modest growth” at best.

Exit Rumours: What Is Actually Happening?

The “exit rumours” referenced in the topic likely stem from confusion between these entities. For the legitimate Nextchem S.p.A., the talk of an “exit” is not about closing down but rather about a potential IPO or sale of a stake by its parent company, MAIRE. As reported in March 2026, MAIRE’s CEO confirmed that the company had received interest from potential investors and was evaluating whether to proceed with a listing or enter discussions with one or more of these parties. This is a story of value realisation, not operational distress.

For the consumer-facing vendors, there is no evidence of formal “exit rumours” in the traditional sense. The concern is rather about domain reliability and longevity. Websites with hidden ownership, recent registration dates, and low trust scores may disappear without notice, leaving customers without recourse. The fact that one domain shows a registration expiry of May 2028 and is protected by multiple client status locks (clientDeleteProhibited, clientRenewProhibited, clientTransferProhibited) suggests an intention to maintain the domain, but WHOIS privacy prevents confirmation of who is behind it .

Conclusion

The answer to whether “Next Chems” is still operating depends entirely on which entity is meant. The legitimate industrial technology provider Nextchem S.p.A. is not only operating but thriving, expanding through acquisitions and major contract wins, with its parent company exploring a potential multi-billion-euro valuation event. The consumer-facing research chemical vendors using similar names present a mixed and cautionary picture: one review site rates one such vendor as moderately trustworthy, while domain analysis services flag multiple related websites as potentially fraudulent with hidden ownership and low trust scores. The Pakistan-based pharmaceutical sourcing firm appears to be operating but with declining web traffic. There is no evidence of a genuine “exit” or closure affecting the legitimate Nextchem business; the rumours appear to conflate a potential parent-company divestment with operational failure.